CLINPATH
DEAD

Serial Number

76705415

Owner

BIOBRIDGES, LLC

Attorney

Robert J. Diettrich

First Use Date

Aug 31, 2010

Filing Date

Nov 19, 2010

Add to watchlist:

No watchlists yet
View on USPTO

CLINPATH Trademark

Serial Number: 76705415 • Registration: 4017447

CLINPATH is a trademark filed by BIOBRIDGES, LLC on November 19, 2010. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BIOBRIDGES, LLC (7 trademarks)

230 3RD AVE.
WALTHAM, MA 02451

Entity Type: 16

Trademark Details

Filing Date

November 19, 2010

Registration Date

August 30, 2011

First Use Anywhere

August 31, 2010

First Use in Commerce

August 31, 2010

Published for Opposition

June 14, 2011

Cancellation Date

April 6, 2018

Goods & Services

Business consultation and business information management services in the fields of biotechnology, pharmaceutical drug and device development and clinical trials, namely, clinical data and regulatory submission management for biotech, pharmaceutical and medical device companies to assist them with clinical research, clinical trials and applications for drug, biologic and medical device approval

Consulting services in the fields of biotechnology, pharmaceutical drug and device development; clinical research and development, namely, conducting clinical trials in the fields of biotechnology, pharmaceutical drug and device development for supporting regulatory filings for pharmaceutical drugs, biologics and medical devices; providing strategic clinical development program evaluation and implementation support for generating and supporting regulatory filings for pharmaceutical drugs, biologics and medical devices, namely, technical writing for biotech, pharmaceutical and medical device companies, clinical research and development in the nature of conducting clinical trials in the fields of biotechnology, pharmaceutical drug and device development, quality evaluation services for the biotech, pharmaceutical and medical device industries, and consultation services in the fields of biotechnology, pharmaceutical drug and device development; consulting services in the fields of biotechnology, pharmaceutical drug and device development; clinical research and development, namely, conducting medical and pharmaceutical clinical trials covering all aspects of drug, biologic and device development tasks; clinical research and development, namely, conducting clinical trials and providing consultation services in the fields of pharmaceutical drugs, biologics and medical devices

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 6, 2018 C8..
REGISTERED-PRINCIPAL REGISTER
Aug 30, 2011 R.PR
PUBLISHED FOR OPPOSITION
Jun 14, 2011 PUBO
NOTICE OF PUBLICATION
May 25, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 6, 2011 PREV
ASSIGNED TO LIE
May 6, 2011 ALIE
EXAMINERS AMENDMENT MAILED
Apr 21, 2011 CNEA
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 21, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 21, 2011 XAEC
EXAMINERS AMENDMENT -WRITTEN
Apr 21, 2011 CNEA
NON-FINAL ACTION MAILED
Mar 8, 2011 CNRT
NON-FINAL ACTION WRITTEN
Mar 8, 2011 CNRT
ASSIGNED TO EXAMINER
Mar 1, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 27, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2010 NWOS